The prognostic value of cancer stem cell markers (cscs) expression—aldh1a1, cd133, cd44—for survival and long-term follow-up of ovarian cancer patients

HIGHLIGHTS

• who: Natalia Izycka et al. from the Department of Gynecology, Obstetrics and Gynecologic Oncology, Division of Gynecologic Oncology, Poznan University of Medical Sciences, Polna , St, Poznanu0301, Poland have published the article: The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expressionu2014ALDH1A1, CD133, CD44u2014For Survival and Long-Term Follow-Up of Ovarian Cancer Patients, in the Journal: (JOURNAL)
• what: This study investigated whether the of known CSC-associated markers ALDH1A and may predict OC patient prognosis.
• future: Investigation of a larger group of EOC patients is required to define its prognostic or predictive significance . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.